Tizanidne Hydrochloride Capsule
Product Images NDC 71335-2209

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 71335-2209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (Lbl713352209)

Label (Lbl713352209)
This text appears to be the description of a medication called Tizanidine Hydrochloride Capsules. Each capsule contains 4.58 mg of Tizanidine, which is equivalent to 4 mg of Tizanidine base. The medication should be kept out of reach of children and stored at a temperature of 25°C (77°F), with excursions permitted between 15° to 30°C (59° to 86°F). It should be dispensed in tight containers with child-resistant closures. The capsules are not interchangeable with tizanidine tablets or Zanaflex® tablets. The NDC code for this medication is 71335-2209-1. The capsules are manufactured by Alkem Laboratories Ltd and relabeled by Bryant Ranch Prepack, Inc. in Burbank, CA.*
FDA Label Image

Tiz01 (Tiz01)

Tiz01 (Tiz01)
FDA Label Image

Tiz02 (Tiz02)

Tiz02 (Tiz02)
FDA Label Image

Tiz03 (Tiz03)

Tiz03 (Tiz03)
FDA Label Image

Tiz04 (Tiz04)

Tiz04 (Tiz04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.